Astrazeneca Coronavirus Vaccine
-
{
- All
- News
- Videos
-
EU Says No Specific Age Risk For AstraZeneca Coronavirus Vaccine So Far
Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are investigating further, the EU's drug regulator said Wednesday.
-
Canada Halts AstraZeneca Shots For Under 55 On Clot Concerns
Health officials in Canada are suspending plans to give AstraZeneca Plc's Covid-19 vaccine to younger people over concerns it could lead to blood clots in rare circumstances.
-
India Delays Big Exports Of AstraZeneca Shot As Infections Surge: Report
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world's biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters.
-
As Pandemic Worsens, Why AstraZeneca Vaccine Is In Spotlight
AstraZeneca has said it is standing by its coronavirus vaccine after a US agency raised concerns about trial results that showed the shot to be highly effective in preventing Covid-19.
-
AstraZeneca's US Trial Shows COVID-19 Vaccine 79 Per Cent Effective
Pharmaceutical giant AstraZeneca said Monday that trials showed its Covid-19 vaccine is 100 percent effective in preventing severe disease, as a row simmered between Britain and the EU over much-needed supplies of the jab.
-
AstraZeneca Safe But "Can't Rule Out" Link To Clotting: Europe Regulator
Europe's medical regulator said Thursday the AstraZeneca vaccine is "safe and effective" and not associated with a higher blood clot risk, after more than a dozen countries paused rollouts over health fears.
-
No Stop On Covishield: Government Sources As Nations Suspend AstraZeneca
There is no question of stopping AstraZeneca's vaccine against coronavirus as of now, sources in the Union Health Ministry said amid blood clot fears that prompted several European Union nations, including Germany, Italy and France, to halt their rollout of the AstraZeneca shot.
-
Oxford Study Shows AstraZeneca Shot Works Against Brazil Strain: Report
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday.
-
Morocco Receives 4 Million Doses Of AstraZeneca Vaccine From India
Morocco received a second batch of 4 million doses of the AstraZeneca coronavirus vaccine on Thursday, having began Africa's first national vaccination campaign two weeks ago, health ministry sources said.
-
Italy Drug Regulator Cautious On Astrazeneca Jab For Over 55s
Italy's medicines agency on Saturday approved the AstraZeneca coronavirus vaccine for all adults but recommended alternatives be given to people aged over 55.
-
German Vaccine Board Recommends AstraZeneca Shots Only For Those Under 65
Germany's vaccine commission STIKO on Thursday said it was recommending the use of AstraZeneca's coronavirus vaccine only for under-65-year-olds, due to insufficient data on its effectiveness on older people.
-
India's Vaccine Diplomacy In South Asia Pushes Back Against China
India will give millions of doses of COVID-19 vaccine to South Asian countries in the next few weeks, government sources told news agency Reuters today, drawing praise from its neighbours and pushing back against China's dominating presence in the region.
-
Lower First Dose Means More People Can Be Vaccinated Faster: AstraZeneca
AstraZeneca's chief executive officer Pascal Soriot said on Monday that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled interim late-stage trial results.
-
EU Says No Specific Age Risk For AstraZeneca Coronavirus Vaccine So Far
Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are investigating further, the EU's drug regulator said Wednesday.
-
Canada Halts AstraZeneca Shots For Under 55 On Clot Concerns
Health officials in Canada are suspending plans to give AstraZeneca Plc's Covid-19 vaccine to younger people over concerns it could lead to blood clots in rare circumstances.
-
India Delays Big Exports Of AstraZeneca Shot As Infections Surge: Report
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world's biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters.
-
As Pandemic Worsens, Why AstraZeneca Vaccine Is In Spotlight
AstraZeneca has said it is standing by its coronavirus vaccine after a US agency raised concerns about trial results that showed the shot to be highly effective in preventing Covid-19.
-
AstraZeneca's US Trial Shows COVID-19 Vaccine 79 Per Cent Effective
Pharmaceutical giant AstraZeneca said Monday that trials showed its Covid-19 vaccine is 100 percent effective in preventing severe disease, as a row simmered between Britain and the EU over much-needed supplies of the jab.
-
AstraZeneca Safe But "Can't Rule Out" Link To Clotting: Europe Regulator
Europe's medical regulator said Thursday the AstraZeneca vaccine is "safe and effective" and not associated with a higher blood clot risk, after more than a dozen countries paused rollouts over health fears.
-
No Stop On Covishield: Government Sources As Nations Suspend AstraZeneca
There is no question of stopping AstraZeneca's vaccine against coronavirus as of now, sources in the Union Health Ministry said amid blood clot fears that prompted several European Union nations, including Germany, Italy and France, to halt their rollout of the AstraZeneca shot.
-
Oxford Study Shows AstraZeneca Shot Works Against Brazil Strain: Report
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday.
-
Morocco Receives 4 Million Doses Of AstraZeneca Vaccine From India
Morocco received a second batch of 4 million doses of the AstraZeneca coronavirus vaccine on Thursday, having began Africa's first national vaccination campaign two weeks ago, health ministry sources said.
-
Italy Drug Regulator Cautious On Astrazeneca Jab For Over 55s
Italy's medicines agency on Saturday approved the AstraZeneca coronavirus vaccine for all adults but recommended alternatives be given to people aged over 55.
-
German Vaccine Board Recommends AstraZeneca Shots Only For Those Under 65
Germany's vaccine commission STIKO on Thursday said it was recommending the use of AstraZeneca's coronavirus vaccine only for under-65-year-olds, due to insufficient data on its effectiveness on older people.
-
India's Vaccine Diplomacy In South Asia Pushes Back Against China
India will give millions of doses of COVID-19 vaccine to South Asian countries in the next few weeks, government sources told news agency Reuters today, drawing praise from its neighbours and pushing back against China's dominating presence in the region.
-
Lower First Dose Means More People Can Be Vaccinated Faster: AstraZeneca
AstraZeneca's chief executive officer Pascal Soriot said on Monday that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled interim late-stage trial results.
